Early research (Phase 1)UnknownNCT06267274
What this trial is testing
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Who this might be right for
Open-angle GlaucomaOcular Hypertension
Amneal Pharmaceuticals, LLC 240